# A Phase I Evaluating Integration of HypofractionatedStudy Renal Ablative Radiotherapy

> **NCT02264548** · PHASE1 · COMPLETED · sponsor: **London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's** · enrollment: 14 (actual)

## Conditions studied

- Renal Cell Carcinoma

## Interventions

- **RADIATION:** Radio-Ablation

## Key facts

- **NCT ID:** NCT02264548
- **Lead sponsor:** London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2020-08-04
- **Final completion:** 2020-08-04
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2023-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02264548

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02264548, "A Phase I Evaluating Integration of HypofractionatedStudy Renal Ablative Radiotherapy". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02264548. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*